by Peggy Baker | Jan 13, 2023 | Clinical, News, Research
Lawrence Robbins, MD Abstract To expand the current description of refractory migraine, the World Headache Society advocates the use of both simple and complex definitions. Simple would be for the general use of patients and support groups, and complex for research...
by Peggy Baker | Jul 25, 2022 | Clinical, News, Research
Lawrence Robbins, MD Evolutionary Medicine is a growing, vital, fascinating and relevant area. I use it daily in my practice, to explain to patients (such as the evolutionary reason for anxiety, why we have so much neck and back pain, why we suffer pain and mortality...
by Peggy Baker | Oct 15, 2021 | Clinical, Research
Olivia Lee and Lawrence Robbins, MD Approximately 9.6% of Americans have a personality disorder.1,2 These are common conditions, and all medical professionals encounter patients with such disorders in their practice. Early identification of this group of patients is...
by Peggy Baker | Apr 8, 2021 | Clinical, News, Research
The CGRP Monoclonal Antibodies for Migraine Are a Prime Example Lawrence Robbins, M.D. This letter is in response to an excellent July, 2020 article “Migraine and CGRP Monoclonal Antibodies: A Review of Cardiovascular Side Effects and Safety Profile” (Boldig and...
by Peggy Baker | Oct 12, 2020 | Clinical, News, Research
Lawrence Robbins, MD INTRODUCTION Migraine often results in disability and diminished quality of life. Despite this, our species remains particularly vulnerable to migraine. Why is this so? Evolution may provide answers. The study of evolution and disease is not...
by Peggy Baker | Jan 12, 2020 | Clinical, News, Research
Lawrence Robbins,M.D. Gepants are small molecule calcitonin gene-related peptide (CGRP) receptor antagonists. The preventive CGRP monoclonal antibodies(Aimovig, Emgality, Ajovy) are large molecules, delivered once per month as a SQ injection. Seven gepants have been...
